Formulation Development of a Nucleotide Phosphoramidate

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-06-02-2003
Volume 27
Issue 6

A small-volume parenteral formulation of NB1011, an enzyme-catalyzed therapeutic activation compound, was successfully developed for intravenous administration.

Recent Videos
US tariff rate rising , trade policy , business graph and dollars banknote , tax calculation change | Image Credit: © janews094 - stock.adobe.com
Related Content